Insider Transactions in Q4 2019 at Accenture PLC (ACN)
Insider Transaction List (Q4 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 05
2019
|
James O Etheredge Chief Exec-North America |
BUY
Grant, award, or other acquisition
|
Direct |
130
+0.72%
|
$24,180
$186.74 P/Share
|
|
Nov 05
2019
|
Daniel T London Group Chief Exec - Health & PS |
BUY
Grant, award, or other acquisition
|
Direct |
141
+0.48%
|
$26,226
$186.74 P/Share
|
|
Nov 05
2019
|
Kathleen R Mc Clure Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
87
+0.4%
|
$16,182
$186.74 P/Share
|
|
Nov 05
2019
|
Domingo Miron Group Chief Executive-Fin Serv |
BUY
Grant, award, or other acquisition
|
Direct |
119
+0.23%
|
$22,134
$186.74 P/Share
|
|
Nov 05
2019
|
Ellyn Shook Chief Leadership & HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
130
+0.48%
|
$24,180
$186.74 P/Share
|
|
Nov 05
2019
|
Julie Spellman Sweet Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
84
+0.49%
|
$15,624
$186.74 P/Share
|
|
Nov 05
2019
|
Joel Unruch General Counsel/Corp Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
107
+0.46%
|
$19,902
$186.74 P/Share
|
|
Nov 05
2019
|
John F Walsh Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
112
+0.47%
|
$20,832
$186.74 P/Share
|
|
Oct 28
2019
|
Ellyn Shook Chief Leadership & HR Officer |
SELL
Open market or private sale
|
Direct |
4,688
-7.58%
|
$862,592
$184.11 P/Share
|
|
Oct 24
2019
|
Gianfranco Casati CEO-Growth Markets |
SELL
Open market or private sale
|
Direct |
24,612
-17.29%
|
$4,577,832
$186.1 P/Share
|
|
Oct 24
2019
|
Richard P Clark Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,752
-8.29%
|
$509,120
$185.81 P/Share
|
|
Oct 24
2019
|
Daniel T London Group Chief Exec - Health & PS |
SELL
Open market or private sale
|
Direct |
5,421
-5.45%
|
$1,008,306
$186.09 P/Share
|
|
Oct 24
2019
|
Julie Spellman Sweet Chair and CEO |
SELL
Open market or private sale
|
Direct |
12,961
-16.67%
|
$2,410,746
$186.11 P/Share
|
|
Oct 23
2019
|
Domingo Miron Group Chief Executive-Fin Serv |
SELL
Open market or private sale
|
Direct |
4,500
-3.97%
|
$823,500
$183.38 P/Share
|
|
Oct 22
2019
|
Omar Abbosh Grp Chief Exec-Com, Med & Tech |
SELL
Payment of exercise price or tax liability
|
Direct |
8,073
-13.83%
|
$1,493,505
$185.22 P/Share
|
|
Oct 22
2019
|
Omar Abbosh Grp Chief Exec-Com, Med & Tech |
BUY
Grant, award, or other acquisition
|
Direct |
17,171
+22.73%
|
-
|
|
Oct 22
2019
|
Gianfranco Casati CEO-Growth Markets |
BUY
Grant, award, or other acquisition
|
Direct |
24,612
+30.67%
|
-
|
|
Oct 22
2019
|
Richard P Clark Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,452
-7.75%
|
$268,620
$185.22 P/Share
|
|
Oct 22
2019
|
Richard P Clark Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,204
+18.32%
|
-
|
|
Oct 22
2019
|
Johan Deblaere Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,765
-13.94%
|
$2,176,525
$185.22 P/Share
|
|
Oct 22
2019
|
Johan Deblaere Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,747
+18.96%
|
-
|
|
Oct 22
2019
|
Simon Eaves Group Chief Executive-Products |
SELL
Payment of exercise price or tax liability
|
Direct |
984
-11.28%
|
$182,040
$185.22 P/Share
|
|
Oct 22
2019
|
Simon Eaves Group Chief Executive-Products |
BUY
Grant, award, or other acquisition
|
Direct |
3,261
+27.2%
|
-
|
|
Oct 22
2019
|
James O Etheredge Chief Exec-North America |
SELL
Payment of exercise price or tax liability
|
Direct |
1,609
-8.24%
|
$297,665
$185.22 P/Share
|
|
Oct 22
2019
|
James O Etheredge Chief Exec-North America |
BUY
Grant, award, or other acquisition
|
Direct |
4,204
+17.72%
|
-
|
|
Oct 22
2019
|
Daniel T London Group Chief Exec - Health & PS |
SELL
Payment of exercise price or tax liability
|
Direct |
7,748
-18.25%
|
$1,433,380
$185.22 P/Share
|
|
Oct 22
2019
|
Daniel T London Group Chief Exec - Health & PS |
BUY
Grant, award, or other acquisition
|
Direct |
17,171
+28.8%
|
-
|
|
Oct 22
2019
|
Domingo Miron Group Chief Executive-Fin Serv |
SELL
Payment of exercise price or tax liability
|
Direct |
1,379
-2.36%
|
$255,115
$185.22 P/Share
|
|
Oct 22
2019
|
Domingo Miron Group Chief Executive-Fin Serv |
BUY
Grant, award, or other acquisition
|
Direct |
3,093
+5.03%
|
-
|
|
Oct 22
2019
|
Jean Marc Ollagnier CEO EMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
386
-0.21%
|
$71,410
$185.22 P/Share
|
|
Oct 22
2019
|
Jean Marc Ollagnier CEO EMEA |
BUY
Grant, award, or other acquisition
|
Direct |
17,171
+8.69%
|
-
|
|
Oct 22
2019
|
David Rowland Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
12,393
-27.41%
|
$2,292,705
$185.22 P/Share
|
|
Oct 22
2019
|
David Rowland Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
27,473
+37.8%
|
-
|
|
Oct 22
2019
|
Ellyn Shook Chief Leadership & HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,223
-18.68%
|
$1,336,255
$185.22 P/Share
|
|
Oct 22
2019
|
Ellyn Shook Chief Leadership & HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,737
+26.21%
|
-
|
|
Oct 22
2019
|
Julie Spellman Sweet Chair and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,651
-27.94%
|
$2,155,435
$185.22 P/Share
|
|
Oct 22
2019
|
Julie Spellman Sweet Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
24,612
+37.11%
|
-
|
|
Oct 22
2019
|
Joel Unruch General Counsel/Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
855
-3.59%
|
$158,175
$185.22 P/Share
|
|
Oct 22
2019
|
Joel Unruch General Counsel/Corp Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
2,910
+10.89%
|
-
|
|
Oct 22
2019
|
Gianfranco Casati CEO-Growth Markets |
SELL
Open market or private sale
|
Direct |
5,000
-2.45%
|
$925,000
$185.59 P/Share
|
|
Oct 22
2019
|
Johan Deblaere Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,000
-0.9%
|
$555,000
$185.25 P/Share
|
|
Oct 22
2019
|
Jean Marc Ollagnier CEO EMEA |
SELL
Open market or private sale
|
Direct |
2,663
-0.32%
|
$492,655
$185.35 P/Share
|
|
Oct 22
2019
|
David Rowland Executive Chairman |
SELL
Open market or private sale
|
Direct |
4,725
-4.59%
|
$874,125
$185.09 P/Share
|
|
Oct 21
2019
|
Joel Unruch General Counsel/Corp Secretary |
SELL
Open market or private sale
|
Direct |
804
-1.87%
|
$149,544
$186.67 P/Share
|
|
Oct 05
2019
|
Omar Abbosh Grp Chief Exec-Com, Med & Tech |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.06%
|
$4,675
$187.96 P/Share
|
|
Oct 05
2019
|
Richard P Clark Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
109
+0.74%
|
$20,383
$187.96 P/Share
|
|
Oct 05
2019
|
Simon Eaves Group Chief Executive-Products |
BUY
Grant, award, or other acquisition
|
Direct |
50
+0.91%
|
$9,350
$187.96 P/Share
|
|
Oct 05
2019
|
James O Etheredge Chief Exec-North America |
BUY
Grant, award, or other acquisition
|
Direct |
130
+0.84%
|
$24,310
$187.96 P/Share
|
|
Oct 05
2019
|
Daniel T London Group Chief Exec - Health & PS |
BUY
Grant, award, or other acquisition
|
Direct |
139
+0.55%
|
$25,993
$187.96 P/Share
|
|
Oct 05
2019
|
Kathleen R Mc Clure Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
87
+0.4%
|
$16,269
$187.96 P/Share
|